Friday, November 15, 2024

AstraZeneca to buy Fusion Pharmaceuticals for up to $2.4 billion

Must read




AstraZeneca is buying Fusion Pharmaceuticals for $2.4 billion as the London-listed group looks to build its presence in cutting-edge cancer treatments.



Source link

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest article